Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
1994 · The Lancet · 511 citations
https://doi.org/10.1016/s0140-6736(94)90008-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
4.6K
Citations
30
h-index
49
i10-index
V. Bramwell is an academic researcher from Alberta Health Services. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Vascular Tumors and Angiosarcomas & Breast Cancer Treatment Studies. The author has an h-index of 30, co-authored 66 publications.
https://doi.org/10.1016/s0140-6736(94)90008-6
https://doi.org/10.1007/s10549-011-1511-5
Click to start Chat